Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
MAGL and ABHD6) in vivo
are also significant independently of maternal serum levels of radiosulfate
6-trihydroxy-8-(3-hydroxy-3-methylbutyl)-7-methoxy-2-(3-methylbut-2-en-1-yl)-9H-xanthen-9-one
InChiKey: JYUWGWCFJMDMND-UHFFFAOYSA-N
(1S, 2S)-Bortezomib Size:Contact [email protected] for quotation MAGL and ABHD6) in vivo(1S,2S) Bortezomib is an enantiomer of Bortezomib. Bortezomib is a cell permeable, reversible, and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki of 0. 6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF B. Bortezomib is an anti cancer agent and the first therapeutic proteasome inhibitor to be used in humans. Product information CAS Number: 1132709 14 8 Molecular
US$ 23.95
US$ 24.95
US$ 15.95
US$ 12.00